Skip to main content
Premium Trial:

Request an Annual Quote

Soros Cuts Stake in CuraGen, Maintains Holding in 454

NEW YORK, Feb 15 – George Soros’ company Soros Fund Management reduced its holding in CuraGen but maintained its stake in CuraGen’s privately held subsidiary, 454, a CuraGen spokesman said Thursday.

“Soros unloaded literally all of his biotech holdings, and we were one that he maintained his position in,” a CuraGen spokesman said. “We saw this as a vote of confidence.”

In an amended Schedule 13G statement filed with the US Securities and Exchange Commission earlier this week, Soros Fund Management indicated that it had reduced its holdings in publicly traded CuraGen to a 1.86 percent stake. In July, Soros owned a 6.48 percent stake in the company.

The CuraGen spokesman said, however, that Soros Fund Management still had a stake in 454, a CuraGen offshoot that is expected to make hardware and software for proteomics and/or genotyping. CuraGen owns 60 percent of 454 and outside investors, including Cooper Hill Partners and Soros Fund Management, own the remainder.

The spokesman said he could not comment on specific plans for 454, but noted that CuraGen would discuss the subsidiary at the upcoming Tri Genome Conference to be held in San Francisco, March 3-9.

The spokesman said CuraGen is currently hiring for 454, which is expected to launch its first product sometime this year.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.